Table 1.
Demographic and clinical characteristics of study participants
| Vitiligo patients | Healthy controls | |
|---|---|---|
| Range of age in years, mean (SD) | 13‐66, 36.35 (14.35) | 15‐67, 35.55 (14.28) |
| Gender, n (%) | ||
| Male | 34 (66.67) | 34 (66.67) |
| Female | 17 (33.33) | 17 (33.33) |
| Range of disease duration in months, mean (SD) | 1‐600, 129.29 (130.76) | NA |
| Disease activity of vitiligo, n (%) | NA | |
| Stable (No progress in past 1 mo) | 20 (39.22) | NA |
| Active (rapidly progress within 1 mo) | 31 (60.78) | NA |
| Lesional skin (n% of BSA) | ||
| <1% | 4 (7.84) | NA |
| 1%‐5% | 21 (41.18) | NA |
| 5%‐50% | 21 (41.18) | NA |
| >50 | 5 (9.80) | NA |
NA, not applicable; SD, standard deviation; BSA, body surface area.